Multiepitope CD8+ T Cell Response to a NY-ESO-1 Peptide Vaccine Results in Imprecise Tumor Targeting

Journal of Clinical Investigation - United States
doi 10.1172/jci16428
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Induction of Primary NY-ESO-1 Immunity: CD8+ T Lymphocyte and Antibody Responses in Peptide-Vaccinated Patients With NY-ESO-1+ Cancers

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

A Melanoma Multiepitope Polypeptide Induces Specific CD8+ T-Cell Response

Cellular Immunology
Immunology
2007English

Regulatory T Cell Depletion Enhances Tumor Specific CD8 T-Cell Responses, Elicited by Tumor Antigen NY-ESO-1b in Hepatocellular Carcinoma Patients, in Vitro

International Journal of Oncology
Cancer ResearchOncology
2010English

Tetramer Guided, Cell Sorter Assisted Production of Clinical Grade Autologous NY-ESO-1 Specific CD8+ T Cells

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Peptide Vaccine Formulation Controls the Duration of Antigen Presentation and Magnitude of Tumor-Specific CD8+T Cell Response

Journal of Immunology
AllergyImmunology
2018English

Function but Not Phenotype of Melanoma Peptide-Specific CD8+ T Cells Correlate With Survival in a Multiepitope Peptide Vaccine Trial (ECOG 1696)

International Journal of Cancer
Cancer ResearchOncology
2012English

NY-ESO-1 Antigen-Reactive T Cell Receptors Exhibit Diverse Therapeutic Capability

International Journal of Cancer
Cancer ResearchOncology
2012English

Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors

Journal of Immunology
AllergyImmunology
2006English

Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity

Vaccines
Drug DiscoveryInfectious DiseasesImmunologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy